1. Home
  2. MOLN vs PEW Comparison

MOLN vs PEW Comparison

Compare MOLN & PEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • PEW
  • Stock Information
  • Founded
  • MOLN 2004
  • PEW 2007
  • Country
  • MOLN Switzerland
  • PEW United States
  • Employees
  • MOLN N/A
  • PEW N/A
  • Industry
  • MOLN
  • PEW Other Specialty Stores
  • Sector
  • MOLN
  • PEW Consumer Discretionary
  • Exchange
  • MOLN Nasdaq
  • PEW Nasdaq
  • Market Cap
  • MOLN 142.5M
  • PEW 143.2M
  • IPO Year
  • MOLN 2021
  • PEW N/A
  • Fundamental
  • Price
  • MOLN $4.24
  • PEW $4.35
  • Analyst Decision
  • MOLN Hold
  • PEW Strong Buy
  • Analyst Count
  • MOLN 1
  • PEW 1
  • Target Price
  • MOLN $4.00
  • PEW $8.25
  • AVG Volume (30 Days)
  • MOLN 7.2K
  • PEW 487.6K
  • Earning Date
  • MOLN 10-30-2025
  • PEW 11-13-2025
  • Dividend Yield
  • MOLN N/A
  • PEW N/A
  • EPS Growth
  • MOLN N/A
  • PEW N/A
  • EPS
  • MOLN N/A
  • PEW N/A
  • Revenue
  • MOLN N/A
  • PEW $90,690,000.00
  • Revenue This Year
  • MOLN N/A
  • PEW N/A
  • Revenue Next Year
  • MOLN $1,000.00
  • PEW $6.69
  • P/E Ratio
  • MOLN N/A
  • PEW $40.17
  • Revenue Growth
  • MOLN N/A
  • PEW N/A
  • 52 Week Low
  • MOLN $3.36
  • PEW $4.17
  • 52 Week High
  • MOLN $6.24
  • PEW $21.40
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 52.81
  • PEW 38.56
  • Support Level
  • MOLN $3.97
  • PEW $4.17
  • Resistance Level
  • MOLN $4.72
  • PEW $4.58
  • Average True Range (ATR)
  • MOLN 0.26
  • PEW 0.23
  • MACD
  • MOLN 0.07
  • PEW -0.00
  • Stochastic Oscillator
  • MOLN 43.44
  • PEW 16.83

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About PEW GrabAGun Digital Holdings Inc. Common Stock

GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition, and related accessories.

Share on Social Networks: